When pharmaceutical companies develop a novel drug for the market, several steps are required to assess and regulate its safety, effectiveness, manufacturability, and reliability. These processes, and ...
This article summarizes a discussion at LSX Biopharm America on September 11. A panel of industry experts discussed approaches to overcoming the most urgent CMC challenges during the discussion. The ...
ProBioGen is launching CMC Navigator, comprised of four clearly defined service models aimed at CMC development.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results